Search

Clinical trials of Allergan's antidepressant rapastinel fail

CLINICAL TRIALS OF ALLERGAN'S ANTIDEPRESSANT RAPASTINEL FAIL

An analyst said the news could negatively affect shares of a successor to the company that developed rapastinel - which Allergan bought...

 
 
 

APTINYX TO PRESENT DATA FOR NYX-2925 IN MODELS OF NEUROPATHIC PAIN AND TRAUMATIC BRAIN INJURY AT NEUROSCIENCE 2016

SAN DIEGO, Nov. 14, 2016 /PRNewswire/ - Aptinyx Inc., a biopharmaceutical company developing novel modulators of the N-methyl-D-aspartate...